Apple at $327.20: A new coronavirus all-time high

Strong close for Apple on Wednesday. Shorts getting covered? Fear of missing out? A little of both?

From AAPLInvestors‘ Terry Gregory, keeper of the stats:

The chart below ranks the top thirty all-time high closing price per share of AAPL. Dates in green indicate closing price was an all-time high at that time.

apple high 327.20 coronavirus

My take: Feels like a pretty volatile situation, but I expect Apple will manage its supply chain problems as least as well as its competitors.

See also: Foxconn talks, Apple pops


  1. David Emery said:
    If the high end Android makers have supply problems, would that drive shoppers over to the iPhone? How sensitive is Samsung to China for parts and manufacturing?

    February 13, 2020
    • Gregg Thurman said:
      Gawd I’m sick of reading about coronavirus.

      February 13, 2020
    • Bart Yee said:
      As I understand it, Samsung has already moved a lot of smartphone manufacturing to Vietnam and India in a quest to lower their labor rates further. Parts undoubtedly still come from some Chinese sources but one would think that Samsung must have some redundancy in their supply chain in case of disruptions. They do source CPUs from MediaTek (fabless Taiwanese chipmaker) and Qualcomm, and of course, Samsung probably provides all its own displays (LCD and OLED) and memory chips.

      February 14, 2020
  2. Robert McDonald said:
    Maybe it’s because DED is focused on long term likelihood vs. the next 6 mo to 1 year prognosis. I believe in investing with both in mind. There is opportunity in both strategies.

    February 13, 2020
  3. Bart Yee said:
    Hi folks, I’m a retired family medicine physician and have been following the China Coronavirus updates. Here’s maybe some first good news on a potential treatment that has show promise in field trials on critically ill patients. The concept of using recovered Coronavirus patients’ plasma that contain antibodies to the virus is similar to how Ebola has been effectively treated in Africa.

    Here’s the relevant details and link to the story from the South China Morning Post, a Hong Kong based news outlet. Here’s hoping this good news pans out and proves effective, potentially saving hundreds of lives at critical risk soon.

    (Of course, this may positively affect AAPL and Foxconn if the plasma treatment proves effective, and the number of recovered cases (estimated at about 6766 cases and growing) may provide a ready pool of virus fighting plasma donors to treat the most critically ill, then moderately ill patients. Any good news on slowing down the virus infections or reversing the morbidity (illness) or mortality (deaths) would likely cheer the market and AAPL and its suppliers. Naturally, this is the first inning of offense against the virus so there is a long way to go but one must be hopeful and potentially grateful for any positive news to this terrible endemic.)

    “Plasma from recovered patients used in virus fight
    China National Biotec Group announced on Thursday evening that virus-neutralising antibodies had been detected in the plasma of patients who have recovered from Covid-19, and experiments have proven they can effectively kill the virus, according to a Beijing News report on Friday.

    The company said it had successfully prepared the plasma for clinical treatment after strict blood biological safety testing, virus inactivation and antiviral activity testing. The plasma had been used to treat 11 patients in critical condition, with significant results, it said.”

    The first phase of the treatment was carried out on three critically ill patients in Wuhan on February 8 and the plasma is currently being used to treat more than 10 critically ill patients.

    Clinical tests showed that, after 12 to 24 hours of treatment, the main inflammatory indicators in the laboratory decreased significantly, the proportion of lymphocytes increased, key indicators such as blood oxygen saturation and viral load improved, and clinical signs and symptoms improved significantly.

    “The plasma product to treat the novel coronavirus is made from plasma loaded with antibodies donated by recovered patients. It went through virus inactivation and was tested against virus-neutralising antibodies and multiple pathogenic microorganisms,” the company said, according to the report.

    February 14, 2020

Leave a Reply